v3.26.1
Condensed Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
 [1]
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Total
Balance at Dec. 31, 2025 $ 843 $ 24,157 $ (83,209) $ (58,209)
Balance (in Shares) at Dec. 31, 2025 8,433,333      
Accretion of Class A ordinary shares subject to redemption amount (18,144,576) (18,144,576)
Sale of Private Placement Warrants 5,000,000 5,000,000
Fair value of Public Warrants at issuance 4,048,000 4,048,000
Fair value of Representative Shares $ 100 9,839,900 9,840,000
Fair value of Representative Shares (in Shares) 1,000,000      
Allocated value of transaction costs to Class A shares (402,601) (402,601)
Net income 1,684,199 1,684,199
Balance at Mar. 31, 2026 $ 100 $ 843 364,880 1,600,990 1,966,813
Balance (in Shares) at Mar. 31, 2026 1,000,000 8,433,333      
Balance at Dec. 31, 2025 $ 843 24,157 (83,209) (58,209)
Balance (in Shares) at Dec. 31, 2025 8,433,333      
Net income         3,718,630
Balance at Jun. 30, 2026 $ 100 $ 843 1,740,651 1,741,594
Balance (in Shares) at Jun. 30, 2026 1,000,000 8,433,333      
Balance at Mar. 31, 2026 $ 100 $ 843 364,880 1,600,990 1,966,813
Balance (in Shares) at Mar. 31, 2026 1,000,000 8,433,333      
Accretion of Class A ordinary shares subject to redemption amount (364,880) (1,894,770) (2,259,650)
Net income 2,034,431 2,034,431
Balance at Jun. 30, 2026 $ 100 $ 843 $ 1,740,651 $ 1,741,594
Balance (in Shares) at Jun. 30, 2026 1,000,000 8,433,333      
[1] As of December 31, 2025, includes up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 8, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,100,000 Founder Shares are no longer subject to forfeiture.